Retningslinjer for diagnostikk og behandling av sår hals

Lakartidningen

Volumn 97, Issue 40, 2000, Pages 4437-4448

  Flottorp, Signe ^a   Oxman, Andrew D ^a   Cooper, John G ^b   Hjortdahl, Per ^c   Sandberg, Sverre ^d   Vorland, Lars H ^e  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b Medisinsk Avdeling   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e Mikrobiologisk Avdeling ^*  (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PENICILLIN DERIVATIVE;

BIOLOGICAL MODEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HUMAN; ISOLATION AND PURIFICATION; META ANALYSIS; MICROBIOLOGY; PATIENT EDUCATION; PHARYNGITIS; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; REVIEW; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; TONSILLITIS;

ANTI-BACTERIAL AGENTS; CONTROLLED CLINICAL TRIALS; EVIDENCE-BASED MEDICINE; HUMANS; META-ANALYSIS; MODELS, BIOLOGICAL; PATIENT EDUCATION; PENICILLINS; PHARYNGITIS; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TONSILLITIS;

EID: 24644506802     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Sår hals-piller, trøst eller begge deler? Et opplegg for kollegagrupper i allmennpraksis. Skien: Sekretariat for utvikling av allmennmedisinske kvalitetsindikatorer [SATS], 1999.
2. McKerrow W, Bisset A, Blair R, Browning G, Dempster J, Morrison J et al. Management for sore throat and indications for tonsillectomy. Edinburgh: Scottish Intercollegiate Guidelines Network (SIGN); 1999. http://pc47.cee.hw.ac.uk/ sign/home.htm (3.11.1999).
3. Hunskår S, Hafting M, Hetlevik I, Holtedahl KA, Johannessen T, Rutle O, red. Allmennmedisin-klinisk arbeid. Oslo: Ad Notam Gyldendal, 1998.
4. Behandling av akutte luftveisinfeksjoner i primærhelsetjenesten. Terapianbefalinger. Oslo: Nytt fra Statens legemiddelkontroll, 1994.
5. Centor RM, Meier FA, Dalton HP. Throat cultures and rapid tests for diagnosis of group A streptococcal pharyngitis in adults. I: Sox H, red. Common diagnostic tests. Use and interpretation. Philadelphia: American College of Physicians, 1990: 245-64.
6. Komaroff AL. Sore throat and acute infectious mononucleosis in adult patients. I: Black ER, Bordley ER, Tape TG, Panzer RJ, red. Diagnostic strategies in common medical problems. Philadelphia: American College of Physicians, 1999: 229-42.
7. Bisno AL, Gerber MA, Gwaltney JMJ, Kaplan EL, Schwartz RH. Diagnosis and management of group A streptococcal pharyng-itis: a practice guideline. Infectious Diseases Society of America. Clin Infect Dis 1997; 25: 574-83.
8. Oxman A, Flottorp S, Cooper JG, Hjortdahl P, Sandberg S, Vorland LH. Nivået på dokumentasjonen og styrken av anbefalingene i kliniske retningslinjer. Tidsskr Nor Lægeforen 2000; 120: 1791-5.
9. Goslings WRO, Valkenburg HA, Bots AW, Lorrier JC. Attack rate of streptococcal pharyngitis, rheumatic fever and of glomerulonefritis in general population. I. Controlled pilot study of streptococcal pharyngitis in one village. N Engl J Med 1963; 268: 687-94.
10. Dagnelie CF, Touw-Otten FW, Kuyvenhoven MM, Rozenberg-Arska M. Bacterial flora in patients presenting with sore throat in Dutch general practice. Fam Pract 1993; 10: 371-7.
11. Hasseltvedt V, Høiby EA, Brubakk O. Alvorlig invasiv gruppe A-infeksjon i 1997 og hittil i 1998-grunn til å være på vakt. MSIS-rapport 1998; 26: 15.
12. Del Mar C, Glasziou PP, Spinks AB. Antibiotics for sore throat. (Cochrane review). I: The Cochrane Library, Issue 1, 2000. Oxford: Update Software, 2000.
13. Hoffmann S, Kolmos HJ. Antibiotikas effekt på symptomer og komplikationer ved halsbetændelse. Kommentar til en metaanalyse fra Cochrane-databasen. Ugeskr Læger 1998; 160: 3373-5.
14. De-Meyere M, Mervielde Y, Verschraegen G, Bogaert M. Effect of penicillin on the clinical course of streptococcal pharyngitis in general practice. Eur J Clin Pharmacol 1992; 43: 581-5.
15. Dagnelie CF, van der Graaf Y, de Melker RA. Do patients with sore throat benefit from penicillin? A randomized double-blind placebo-controlled clinical trial with penicillin V in general practice. Br J Gen Pract 1996; 46: 589-93.
16. Zwart S, Sachs AP, Ruijs GJ, Gubbels JW, Hoes AW, de Melker RA. Penicillin for acute sore throat: randomised double blind trial of seven days versus three days treatment or placebo in adults. BMJ 2000; 320: 150-4.
17. Hoffmann S, Henrichsen J, Schmidt K. Diagnostic og incidens af gigtfeber i Danmark i 1980 og 1983. Ugeskr Læger 1987; 149: 2277-82.
18. Gordis L. Effectiveness of comprehensive-care programs in preventing rheumatic fever. N Engl J Med 1973; 289: 331-5.
19. Wallace MR, Garst PD, Papadimos TJ, Oldfield EC. The return of acute rheumatic fever in young adults. JAMA 1989; 262: 2557-61.
20. Haverkorn MJ, Valkenburg HA, Goslings WR. Streptococcal pharyngitis in the general population. I. A controlled study of streptococcal pharyngitis and its complications in the Netherlands. J Infect Dis 1971; 124: 339-47.
21. Little P, Williamson I. Sore throat management in general practice. Fam Pract 1996; 13: 317-21.
22. Kværner KJ, Mair IW. Akutt og residiverende akutt othis media. Tidsskr Nor L̊geforen 1997; 117: 4096-8.
23. Hasseltvedt V, Høiby EA. Svært høy forekomst av alvorlig invasiv GAS-sykdom i 1998-og hittil i 1999. MSIS-rapport 1999; 27: 12.
24. Stevens DL. The flesh-eating bacterium: what's next? J Infect Dis 1999; 179: 366-74.
25. Bucher A, Martin PR, Hoiby EA, Halstensen A, Odegaard A, Helium KB et al. Spectrum of disease in bacteraemic patients during a Streptococcus pyogenes serotype M-1 epidemic in Norway in 1988. Eur J Clin Microbiol Infect Dis 1992; 11: 416-26.
26. Kongelf E, Rosseland LA, von der Lippe E, Mair IWS. Alvorlige streptokokkinfeksjoner i øre-nese-halsområdet. Tidsskr Nor Lægeforen 1997; 117: 32-5.
27. Breese BB, Disney FA. Factors influencing the spread of beta hemolytic streptococcal infections within the family group. Pediatrics 1956; 17: 834-8.
28. Sørensen HT, Nielsen B, Østergaard NJ. Anaphylactic shock occurring outside hospitals. Allergy 1989; 44: 288-90.
29. Idsøe O, Guthe T, Willcox RR, Weck AL. Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. Bull World Health Organ 1968; 38: 159-88.
30. Ström J. Penicillin treatment and immunity to scarlatina. Acta Paediatr 1954; 43: 267-79.
31. Pichichero ME, Disney FA, Talpey WB, Green JL, Francis AB, Roghmann KJ et al. Adverse and beneficial effects of immediate treatment of Group A beta-hemolytic streptococcal pharyngitis with penicillin. Pediatr Infect Dis J 1987; 6: 635-43.
32. el-Daher NT, Hijazi SS, Rawashdeh NM, alKhalil IA, Abu-Ektaish FM, Abdel-Latif DI. Immediate vs. delayed treatment of group A beta-hemolytic streptococcal pharyngitis with penicillin V. Pediatr Infect Dis J 1991; 10: 126-30.
33. Little P, Gould C, Williamson I, Warner G, Gantley M, Kinmonth AL. Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicalising effect of prescribing antibiotics. BMJ 1997; 315: 350-2.
34. Hareide B, Aavitsland P, Høiby EA. Plan for å motvirke antibiotikaresistens. Oslo: Statens institutt for folkehelse, 1999.
35. Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997; 337: 441-6.
36. Melander E, Molstad S, Persson K, Hansson HB, Soderstrom M, Ekdahl K. Previous antibiotic consumption and other risk factors for carriage of penicillin-resistant Streptococcus pneumoniae in children. Eur J Clin Microbiol Infect Dis 1998; 17: 834-8.
37. Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen. A practitionerbased randomized clinical trial. JAMA 1995; 273: 929-33.
38. Moore N, Van Ganse E, Le Parc JM, Wall R, Schneid H, Farhan M et al. The PAIN study: paracetamol, aspirin and ibuprofen new tolerability study. Clin Drug Invest 1999; 18: 89-98.
39. Olsson B, Tibblin G. Effect of patients' expectations on recovery from acute tonsillitis. Fam Pract 1989; 6: 188-92.
40. Stewart MA. Effective physician-patient communication and health outcomes: a review. CMAJ 1995; 152: 1423-33.
41. Del Mar C. Managing sore throat: a literature review. I. Making the diagnosis. Med J Aust 1992; 156: 572-5.
42. Schachtel BP, Fillingim JM, Beiter DJ, Lane AC, Schwartz LA. Subjective and objective features of sore throat. Arch Intern Med 1984; 144: 497-500.
43. Valkenburg HA, Haverkorn MJ, Goslings WR, Lorrier JC, De Moor CE, Maxted WR. streptococcal pharyngitis in the general population. II. The attack rate of rheumatic fever and acute glomerulonephritis in patients. J Infect Dis 1971; 124: 348-58.
44. Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency room. Med Decis Making 1981; 1: 39-46.
45. Hoffmann S. An algorithm for a selective use of throat swabs in the diagnosis of group A streptococcal pharyngo-tonsillitis in general practice. Scand J Prim Health Care 1992; 10: 295-300.
46. McIsaac WJ, White D, Tannenbaum D, Low DE. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ 1998; 158: 75-83.
47. McIsaac WJ, Goel V, Slaughter PM, Parsons GW, Woolnough KV, Weir PT et al. Reconsidering sore throats. Part 2: Alternative approach and practical office tool. Can Fam Physician 1997; 43: 495-500.
48. Gulich MS, Matschiner A, Gluck R, Zeitler HP. Improving diagnostic accuracy of bacterial pharyngitis by near patient measurement of C-reactive protein (CRP). Br J Gen Pract 1999; 49: 119-21.
49. Hjortdahl P, Melbye H. Does near-to-patient testing contribute to the diagnosis of streptococcal pharyngitis in adults? Scand J Prim Health Care 1994; 12: 70-6.